Solesence (SLSN) Common Equity (2010 - 2026)

Solesence's Common Equity history runs 17 years deep, the most recent figure standing at $17.0 million for Q1 2026.

• Quarterly Common Equity rose 11.95% year-over-year to $17.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.0 million (up 11.95% YoY) and the FY2025 annual result came in at $17.6 million, up 17.98% from the prior year.
• Common Equity was $17.0 million for Q1 2026 at Solesence, down from $17.6 million in the prior quarter.
• Across five years, Common Equity topped out at $18.2 million in Q2 2025 and bottomed at $1.9 million in Q4 2023.
• A 5-year average of $10.4 million and a median of $8.0 million in 2022 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2023 — Common Equity tumbled 66.33% — and 2024, when it jumped 685.8%.
• Solesence's Common Equity stood at $5.6 million in 2022, then plunged by 66.33% to $1.9 million in 2023, then soared by 685.8% to $14.9 million in 2024, then climbed by 17.98% to $17.6 million in 2025, then fell by 3.78% to $17.0 million in 2026.
• Business Quant data shows SLSN's Common Equity at $17.0 million in Q1 2026, $17.6 million in Q4 2025, and $17.2 million in Q3 2025.